Structured evidence table for Bergamot Cardiometabolic Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Bergamot Cardiometabolic Meta-Analysis | Bergamot ( Citrus bergamia ), a flavonoid-rich nutraceutical, has shown potential cardiometabolic benefits, yet evidence from human trials remains inconsistent. | 1 | Chambari M (2026) | Bergamot (<i>Citrus bergamia</i>) Supplementation and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis. |
| Bergamot Cardiometabolic Meta-Analysis | This systematic review and dose-response meta-analysis evaluated the effects of bergamot ( Citrus bergamia ) on cardiovascular disease risk factors in adults. | 1 | Chambari M (2026) | Bergamot (<i>Citrus bergamia</i>) Supplementation and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis. |
| Bergamot Cardiometabolic Meta-Analysis | The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. | 1 | Chambari M (2026) | Bergamot (<i>Citrus bergamia</i>) Supplementation and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis. |
| Bergamot Cardiometabolic Meta-Analysis | Background Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in Western countries, characterized by excessive fat storage in the form of lipid droplets (LDs) in hepatocytes; it is also called Metabolic-Associated Steatotic Liver Disease (MASLD), if coexisting with at least one cardiometabolic risk factor. | 4 | Riillo C (2025) | Bergamot Polyphenols Reduce Hepatic Lipogenesis While Boosting Autophagy and Short-Chain Fatty Acid Production in a Murine "Cafeteria" Model of MASLD. |
| Bergamot Cardiometabolic Meta-Analysis | Bergamot polyphenols (BPF) have been shown to counteract hepatic LD accumulation through potent lipogenesis suppression and associated metabolic benefits in Wistar rats, but their liver-specific anti-lipogenic effects may be species- and strain-dependent. | 4 | Riillo C (2025) | Bergamot Polyphenols Reduce Hepatic Lipogenesis While Boosting Autophagy and Short-Chain Fatty Acid Production in a Murine "Cafeteria" Model of MASLD. |
| Bergamot Cardiometabolic Meta-Analysis | This was associated with a significant increase in blood glucose, triglycerides, and total cholesterol levels, and a decrease in caecal short-chain fatty acids (SCFAs). | 4 | Riillo C (2025) | Bergamot Polyphenols Reduce Hepatic Lipogenesis While Boosting Autophagy and Short-Chain Fatty Acid Production in a Murine "Cafeteria" Model of MASLD. |
Source documents